NIOX Group (LON:NIOX) Stock Price Down 1.5% – What’s Next?

NIOX Group Plc (LON:NIOX)’s stock price fell 1.5% during trading on Thursday . The stock traded as low as GBX 63.60 ($0.86) and last traded at GBX 64 ($0.86). 179,760 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 1,235,947 shares. The stock had previously closed at GBX 65 ($0.87).

Analyst Ratings Changes

Several brokerages have recently commented on NIOX. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 90 ($1.21) target price on shares of NIOX Group in a research note on Tuesday, April 15th. Berenberg Bank restated a “buy” rating and issued a GBX 90 ($1.21) target price on shares of NIOX Group in a research note on Tuesday, April 15th.

NIOX Group Price Performance

The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.94 and a current ratio of 6.31. The company’s 50 day moving average price is GBX 65.20 and its 200 day moving average price is GBX 64.24. The company has a market cap of £26.29 billion, a price-to-earnings ratio of 2,641.17 and a beta of 0.92.

NIOX Group (LON:NIOX) last released its quarterly earnings results on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) earnings per share (EPS) for the quarter. NIOX Group had a return on equity of 13.29% and a net margin of 28.21%. On average, equities research analysts predict that NIOX Group Plc will post 1.1658256 earnings per share for the current fiscal year.

Insider Activity at NIOX Group

In other NIOX Group news, insider Ian Johnson sold 3,924,630 shares of the business’s stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of GBX 65 ($0.87), for a total transaction of £2,551,009.50 ($3,430,620.63). Also, insider Jonathan Emms sold 2,745,925 shares of the business’s stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of GBX 65 ($0.87), for a total value of £1,784,851.25 ($2,400,284.09). 46.72% of the stock is currently owned by company insiders.

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.